TROOPS OF OPERATION WHIRL STROKE ARREST HIGH PROFILE CRIMINAL IN BENUE COMMUNITY. (PHOTO).#PRESS RELEASE

Image
 TROOPS OF OPERATION WHIRL STROKE ARREST HIGH PROFILE CRIMINAL IN BENUE COMMUNITY Troops of Operation WHIRL STROKE arrested a high-profile suspected criminal during an intelligence-driven operation in Agasha Village of Guma Local Government Area, Benue State, following a report of an attack on a local resident. The operation was launched on 13 March 2026 after security agencies received credible information regarding an attack on Mr Shaapera Seeta Michael in Agasha Village. Acting swiftly on the report, troops of the Chief of Army Staff (COAS) Intervention Battalion XI deployed under Operation WHIRL STROKE mobilised immediately to the affected area to track down the suspect responsible for the assault. Upon arrival, the troops cordoned the area to prevent the suspect from escaping while conducting a targeted search operation aimed at identifying and apprehending the alleged attacker. The suspected militia member identified as Mr Suurnen David Akum, aged 27, from Agasha Village in G...

GSK CEO TO RESIGN BY THE END OF THE YEAR. (PHOTO).


 GSK CEO to resign by the end of the year

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down on Dec. 31 after more than eight years at the helm of the London-based drugmaker.

Walmsley, 56, will be succeeded by Luke Miels, currently GSK’s chief commercial officer, the company announced Monday. During her tenure, Walmsley oversaw several strategic initiatives, including the spinoff of the consumer health business Haleon, but the company’s overall performance has underwhelmed investors. GSK shares rose 3.3% to 1,534.50 pence in early trading, making it the top gainer on the London Stock Exchange.

Despite these gains, GSK’s stock has fallen 11% since Walmsley took over on April 1, 2017. Analysts say the company has delivered on financial guidance but continues to experience slow growth. Derren Nathan, head of equity research at U.K.-based Hargreaves Lansdown, noted that while GSK has achieved progress, “the share price performance has been lackluster” and growth rates remain in the single digits.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.